Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer

NCT02590003 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Trial was stopped after non-response to treatment.

Conditions

Carcinoma, Non-small Cell Lung

Interventions

DRUG: Carboplatin
DRUG: Nab-paclitaxel

Sponsor

Yale University